OPK Earnings Date: Nov 4, 2026 (Estimated) — Opko Health Inc.
XNAS · Healthcare · Medical - Diagnostics & Research
Updated
When is OPK's next earnings date?
Opko Health Inc. (OPK) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.07 on revenue of $136.6M.
How did OPK do in its last earnings report?
In its most recent report on Jul 27, 2026 (Q2 2026), Opko Health Inc. posted EPS of -$0.01 versus the -$0.10 estimate, a beat of 90.0%. Revenue was $163.5M against a $131.2M estimate.
How much does OPK stock move after earnings?
OPK beat EPS estimates in 5 of its last 8 reported quarters. Over the last 2 reports the stock moved an average of 4.5% (up or down) in the day after earnings.
About Opko Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-27 | Q2 2026 | -0.10 | -0.01 | +90.00% | $163.5M | ✅ Beat | — | — | — |
| 2026-04-28 | Q1 2026 | -0.07 | -0.07 | +0.00% | $124.2M | ➖ Inline | — | — | — |
| 2026-02-26 | Q4 2025 | -0.07 | -0.04 | +42.86% | $148.5M | ✅ Beat | — | — | — |
| 2025-10-29 | Q3 2025 | -0.04 | -0.10 | -150.00% | $151.7M | ❌ Miss | — | — | — |
| 2025-07-31 | Q2 2025 | -0.11 | -0.07 | +36.36% | $156.8M | ✅ Beat | — | — | — |
| 2025-04-30 | Q1 2025 | -0.11 | -0.10 | +9.09% | $149.9M | ✅ Beat | -2.17% | -9.42% | -1.45% |
| 2025-02-27 | Q4 2024 | -0.11 | 0.02 | +118.18% | $183.6M | ✅ Beat | +6.75% | +15.95% | +4.29% |
| 2024-11-07 | Q3 2024 | -0.09 | -0.09 | — | $173.6M | ➖ Inline | — | — | — |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $163.6M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Service | 45.6% | $74.5M | -26.3% | $103.1M | $102.8M | $101.1M | $95.2M |
| Transfer of Intellectual Property and Other | 28.2% | $46.1M | +208.0% | $43.1M | $12.3M | $15.0M | $18.7M |
| Product | 26.3% | $42.9M | +5.4% | $37.4M | $34.8M | $40.7M | $37.7M |
By region
Q2 FY26 · $163.6M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 54.3% | $88.8M | -22.7% | $135.9M | $116.2M | $114.9M | $110.9M |
| IRELAND | 25.5% | $41.7M | +254.8% | $17.8M | $5.5M | $11.7M | $12.1M |
| CHILE | 10.0% | $16.4M | +2.7% | $16.0M | $14.5M | $16.0M | $14.4M |
| SPAIN | 5.2% | $8.5M | +25.7% | $6.8M | $6.4M | $6.7M | $6.3M |
| MEXICO | 4.3% | $7.0M | +11.8% | $5.2M | $6.2M | $6.3M | $6.7M |
| Other Countries | 0.7% | $1.2M | +16.5% | $933K | $992K | $1.0M | $1.1M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.